DNA damage-induced apoptosis: insights from the mouse

被引:17
作者
Zabkiewicz, J [1 ]
Clarke, AR [1 ]
机构
[1] Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2004年 / 1705卷 / 01期
关键词
p53; mismatch repair; apoptosis; murine model; tumorigenesis; clonogenic survival; mutation;
D O I
10.1016/j.bbcan.2004.09.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The availability of murine models with precisely defined genetic lesions has greatly increased our understanding of the genetic control of cell death, with functional dependence established for a wide range of genes including (amongst others) the p53 and Bcl-2 gene family members, the mismatch repair (MMR) genes and the methyl binding domain family member Mbd4. These studies raised the attractive hypotheses that tumour predisposition may be explained in terms of failed cell death, and also that tumour regression may be initiated through activation of an apoptotic programme. The studies that have addressed these notions have revealed complex consequences of a failed death programme, such that these simple hypotheses have not always been supported. Remarkably, however, some tissues show more predictable responses than others, most apparent in the contrast between the intestine and the haematopoietic system. This review will focus upon a discussion of these relationships, and will also consider the relevance of some of these findings to tumour predisposition and regression. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 78 条
[1]   THE C-MYC ONCOGENE DRIVEN BY IMMUNOGLOBULIN ENHANCERS INDUCES LYMPHOID MALIGNANCY IN TRANSGENIC MICE [J].
ADAMS, JM ;
HARRIS, AW ;
PINKERT, CA ;
CORCORAN, LM ;
ALEXANDER, WS ;
CORY, S ;
PALMITER, RD ;
BRINSTER, RL .
NATURE, 1985, 318 (6046) :533-538
[2]  
Arango D, 2001, CANCER RES, V61, P4910
[3]   Elevated mutant frequencies and increased C:G→T:A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells [J].
Baross-Francis, A ;
Makhani, N ;
Liskay, RM ;
Jirik, FR .
ONCOGENE, 2001, 20 (05) :619-625
[4]   Spontaneous mutation frequencies and spectra in p53 (+/+) and p53 (-/-) mice: A test of the 'guardian of the genome' hypothesis in the Big Blue(R) transgenic mouse mutation detection system [J].
Buettner, VL ;
Nishino, H ;
Haavik, J ;
Knoll, A ;
Hill, K ;
Sommer, SS .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1997, 379 (01) :13-20
[5]   Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].
Bunz, F ;
Hwang, PM ;
Torrance, C ;
Waldman, T ;
Zhang, YG ;
Dillehay, L ;
Williams, J ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269
[6]   Essential role for oncogenic Ras in tumour maintenance [J].
Chin, L ;
Tam, A ;
Pomerantz, J ;
Wong, M ;
Holash, J ;
Bardeesy, N ;
Shen, Q ;
O'Hagan, R ;
Pantginis, J ;
Zhou, H ;
Horner, JW ;
Cordon-Cardo, C ;
Yancopoulos, GD ;
DePinho, RA .
NATURE, 1999, 400 (6743) :468-472
[7]  
CLARKE AR, 1995, ONCOGENE, V11, P1913
[8]  
Clarke AR, 2003, ONCOL RES, V13, P333
[9]   Mouse models with modified p53 sequences to study cancer and ageing [J].
Clarke, AR ;
Hollstein, M .
CELL DEATH AND DIFFERENTIATION, 2003, 10 (04) :443-450
[10]  
CLARKE AR, 1994, ONCOGENE, V9, P1767